Legacy Wealth Asset Management LLC purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 3,036 shares of the semiconductor company’s stock, valued at approximately $1,498,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Symphony Financial Ltd. Co. increased its stake in shares of Synopsys by 4,780.9% during the 2nd quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after purchasing an additional 39,395 shares during the last quarter. HBW Advisory Services LLC lifted its stake in Synopsys by 494.9% in the second quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock valued at $1,851,000 after purchasing an additional 3,004 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in Synopsys by 0.4% during the second quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after purchasing an additional 4,815 shares during the period. Westbourne Investments Inc. bought a new position in Synopsys during the second quarter valued at $1,505,000. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in Synopsys by 1.7% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 178,786 shares of the semiconductor company’s stock valued at $91,660,000 after purchasing an additional 2,991 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages have recently commented on SNPS. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Stifel Nicolaus lowered their price objective on Synopsys from $650.00 to $550.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Needham & Company LLC increased their target price on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research note on Wednesday, October 8th. Eleven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $562.13.
Synopsys News Roundup
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: KeyCorp reiterated bullish coverage and published multi‑year EPS projections and a $600 price target, which supports upside expectations for SNPS and likely helped buying interest. KeyCorp estimates and MarketBeat summary
- Neutral Sentiment: Zacks and other outlets note elevated investor attention in SNPS; increased retail/institutional focus can amplify moves in either direction but does not by itself change fundamentals. Zacks: Investor Attention
- Neutral Sentiment: MarketWatch flagged that SNPS underperformed peers on a relative basis despite daily gains — a reminder that sector rotation and peer performance are constraining factors. MarketWatch: Relative Performance
- Negative Sentiment: Multiple securities‑fraud class‑action notices and law‑firm solicitations have been filed or distributed, alleging material misstatements for purchases made between Dec. 4, 2024 and Sept. 9, 2025; the widely publicized Dec. 30, 2025 lead‑plaintiff deadline increases headline risk and potential legal exposure. GlobeNewswire: Class Action Filed
- Negative Sentiment: Several plaintiff firms (Rosen, Levi & Korsinsky, Faruqi & Faruqi, Bleichmar Fonti & Auld, Schall, Gross, etc.) are soliciting lead‑plaintiff applications — this broad outreach typically precedes contested litigation phases that can drive volatility and potentially settlement costs or reputational damage. Example notice: Rosen Law Firm: Final Deadline Notice
Synopsys Stock Up 1.2%
SNPS stock opened at $463.73 on Monday. The stock has a 50-day simple moving average of $434.19 and a two-hundred day simple moving average of $504.21. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The firm has a market capitalization of $86.14 billion, a PE ratio of 58.04, a PEG ratio of 3.86 and a beta of 1.16. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. Synopsys’s revenue was up 37.8% compared to the same quarter last year. During the same period last year, the business earned $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, equities analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Wall Street Stock picker Names #1 Stock of 2026
- End of America update
- They Laughed at $30. They Won’t Laugh at $70.
- The McDonald’s Secret
- How Long Will $1M Last in Retirement?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
